Anti-IL-23p19 therapy inhibits the adoptive transfer of syngeneic graft-versus-host disease

Cytokine

Volumn 61, Issue 3, 2013, Pages 732-735

  Anthony Brandon, J ^a   Darrell Jennings, C ^a   Kaplan, Alan M ^a   Scott Bryson, J ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

CD4+ T cells; Cyclosporine A; Interleukin 23; Mucosal inflammation; Transplantation

Indexed keywords

INTERLEUKIN 23; INTERLEUKIN 23 ANTIBODY; INTERLEUKIN 23P19 ANTIBODY; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLITIS; CONTROLLED STUDY; CYTOKINE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; EFFECTOR CELL; FEMALE; GRAFT VERSUS HOST REACTION; ISOGRAFT; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNGENEIC GRAFT VERSUS HOST REACTION; TH1 CELL; TH17 CELL;

ADOPTIVE TRANSFER; ANIMALS; CYTOKINES; FEMALE; GRAFT VS HOST DISEASE; INFLAMMATION MEDIATORS; INTERLEUKIN-23 SUBUNIT P19; MICE; TRANSPLANTATION, ISOGENEIC;

EID: 84875378439     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.01.005     Document Type: Article

References (15)

1. Glazier A., Tutschka P.J., Farmer E.R., Santos G.W. Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution. J Exp Med 1983, 158:1-8.
2. + T cells mediate murine syngeneic graft-versus-host disease-associated colitis. J Immunol 2004, 172:679-687.
3. + T cells. J Leukoc Biol 2007, 82:1393-1400.
4. Brandon J.A., Jennings C.D., Kaplan A.M., Bryson J.S. Murine syngeneic graft-versus-host disease is responsive to broad-spectrum antibiotic therapy. J Immunol 2011, 186:3726-3734.
5. Baumgart D.C., Carding S.R. Inflammatory bowel disease: cause and immunobiology. Lancet 2007, 369:1627-1640.
6. Mowat A.M. Antibodies to IFN-gamma prevent immunologically mediated intestinal damage in murine graft-versus-host reaction. Immunology 1989, 68:18-23.
7. Monteleone I., Pallone F., Monteleone G. Interleukin-23 and Th17 cells in the control of gut inflammation. Mediators Inflamm 2009, 2009:297645.
8. H17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease. Blood 2007, 110:3804-3813.
9. Oppmann B., Lesley R., Blom B., Timans J.C., Xu Y., Hunte B., et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000, 13:715-725.
10. Flanagan D.L., Jennings C.D., Bryson J.S. Th1 cytokines and NK cells participate in the development of murine syngeneic graft-versus-host disease. J Immunol 1999, 163:1170-1177.
11. Brandon JA, Jennings CD, Kaplan AM, Bryson JS. Development of a T(H)17 immune response during the induction of murine syngeneic graft-versus-host disease. Cytokine; 2010.
12. Elson C.O., Cong Y., Weaver C.T., Schoeb T.R., McClanahan T.K., Fick R.B., et al. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Gastroenterology 2007, 132:2359-2370.
13. Hess A.D., Thoburn C.J., Chen W., Horwitz L.R. Complexity of effector mechanisms in cyclosporine-induced syngeneic graft-versus-host disease. Biol Blood Marrow Transplant 2000, 6:13-24.
14. Thoburn C.J., Miura Y., Bright E.C., Hess A.D. Functional divergence of antigen-specific T-lymphocyte responses in syngeneic graft-versus-host disease. Biol Blood Marrow Transplant 2004, 10:591-603.
15. Uhlig H.H., McKenzie B.S., Hue S., Thompson C., Joyce-Shaikh B., Stepankova R., et al. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 2006, 25:309-318.